Insider Actions for Gilead Sciences Inc.
03/01/2023 |
Daniel P. O'Day Chairman & CEO; Director |
4,842 | Derivative/Non-derivative trans. at $79.59 per share. | 385,374 |
03/01/2023 |
Merdad V. Parsey Chief Medical Officer |
12,984 | Disposition at $79.96 per share. | 1,038,200 |
03/01/2023 |
Daniel P. O'Day Chairman & CEO; Director |
11,362 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/15/2023 |
Andrew D. Dickinson Chief Financial Officer |
376 | Award at $56.38 per share. | 21,198 |
02/15/2023 |
Merdad V. Parsey Chief Medical Officer |
376 | Award at $56.38 per share. | 21,198 |
02/15/2023 |
Deborah H. Telman EVP, Corporate Affairs & GC |
376 | Award at $56.38 per share. | 21,198 |
02/06/2023 |
Andrew D. Dickinson Chief Financial Officer |
531 | Derivative/Non-derivative trans. at $86.36 per share. | 45,857 |
02/06/2023 |
Diane E. Wilfong SVP, Controller & CAO |
565 | Derivative/Non-derivative trans. at $86.36 per share. | 48,793 |
02/06/2023 |
Andrew D. Dickinson Chief Financial Officer |
1,817 | Derivative/Non-derivative trans. at $0 per share. | 0 |
02/06/2023 |
Diane E. Wilfong SVP, Controller & CAO |
1,864 | Derivative/Non-derivative trans. at $0 per share. | 0 |
01/24/2023 |
Daniel P. O'Day Chairman & CEO; Director |
59,078 | Derivative/Non-derivative trans. at $84.02 per share. | 4,963,733 |
01/24/2023 |
Andrew D. Dickinson Chief Financial Officer |
15,327 | Derivative/Non-derivative trans. at $84.02 per share. | 1,287,774 |
01/24/2023 |
Johanna Mercier Chief Commercial Officer |
15,325 | Derivative/Non-derivative trans. at $84.02 per share. | 1,287,606 |
01/24/2023 |
Merdad V. Parsey Chief Medical Officer |
17,749 | Derivative/Non-derivative trans. at $84.02 per share. | 1,491,270 |
01/24/2023 |
Diane E. Wilfong SVP, Controller & CAO |
1,244 | Derivative/Non-derivative trans. at $84.02 per share. | 104,520 |
01/24/2023 |
Daniel P. O'Day Chairman & CEO; Director |
136,647 | Award at $0 per share. | 0 |
01/24/2023 |
Daniel P. O'Day Chairman & CEO; Director |
78,370 | Award at $0 per share. | 0 |
01/24/2023 |
Andrew D. Dickinson Chief Financial Officer |
38,270 | Award at $0 per share. | 0 |
01/24/2023 |
Andrew D. Dickinson Chief Financial Officer |
27,932 | Award at $0 per share. | 0 |
01/24/2023 |
Johanna Mercier Chief Commercial Officer |
38,270 | Award at $0 per share. | 0 |
01/24/2023 |
Johanna Mercier Chief Commercial Officer |
29,124 | Award at $0 per share. | 0 |
01/24/2023 |
Merdad V. Parsey Chief Medical Officer |
43,715 | Award at $0 per share. | 0 |
01/24/2023 |
Merdad V. Parsey Chief Medical Officer |
29,644 | Award at $0 per share. | 0 |
01/24/2023 |
Diane E. Wilfong SVP, Controller & CAO |
4,100 | Award at $0 per share. | 0 |
01/24/2023 |
Diane E. Wilfong SVP, Controller & CAO |
1,784 | Award at $0 per share. | 0 |
12/30/2022 |
Merdad V. Parsey Chief Medical Officer |
553 | Disposition at $85.33 per share. | 47,187 |
12/10/2022 |
Daniel P. O'Day Chairman & CEO; Director |
1,542 | Derivative/Non-derivative trans. at $87.97 per share. | 135,649 |
12/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
480 | Derivative/Non-derivative trans. at $87.97 per share. | 42,225 |
12/10/2022 |
Johanna Mercier Chief Commercial Officer |
463 | Derivative/Non-derivative trans. at $87.97 per share. | 40,730 |
12/10/2022 |
Merdad V. Parsey Chief Medical Officer |
486 | Derivative/Non-derivative trans. at $87.97 per share. | 42,753 |
12/10/2022 |
Diane E. Wilfong SVP, Controller & CAO |
149 | Derivative/Non-derivative trans. at $87.97 per share. | 13,107 |
12/10/2022 |
Daniel P. O'Day Chairman & CEO; Director |
3,300 | Derivative/Non-derivative trans. at $0 per share. | 0 |
12/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
1,027 | Derivative/Non-derivative trans. at $0 per share. | 0 |
12/10/2022 |
Johanna Mercier Chief Commercial Officer |
990 | Derivative/Non-derivative trans. at $0 per share. | 0 |
12/10/2022 |
Merdad V. Parsey Chief Medical Officer |
1,039 | Derivative/Non-derivative trans. at $0 per share. | 0 |
12/10/2022 |
Diane E. Wilfong SVP, Controller & CAO |
318 | Derivative/Non-derivative trans. at $0 per share. | 0 |
11/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
851 | Derivative/Non-derivative trans. at $82.6 per share. | 70,292 |
11/10/2022 |
Merdad V. Parsey Chief Medical Officer |
2,268 | Derivative/Non-derivative trans. at $82.6 per share. | 187,336 |
11/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
1,912 | Derivative/Non-derivative trans. at $0 per share. | 0 |
11/10/2022 |
Merdad V. Parsey Chief Medical Officer |
5,099 | Derivative/Non-derivative trans. at $0 per share. | 0 |
11/09/2022 |
Diane E. Wilfong SVP, Controller & CAO |
6,416 | Disposition at $83.5 per share. | 535,736 |
11/09/2022 |
Diane E. Wilfong SVP, Controller & CAO |
6,416 | Derivative/Non-derivative trans. at $63.91 per share. | 410,046 |
11/01/2022 |
Diane E. Wilfong SVP, Controller & CAO |
16,255 | Disposition at $79.25 per share. | 1,288,208 |
11/01/2022 |
Diane E. Wilfong SVP, Controller & CAO |
16,255 | Derivative/Non-derivative trans. at $72.7 per share. | 1,181,738 |
09/10/2022 |
Daniel P. O'Day Chairman & CEO; Director |
1,528 | Derivative/Non-derivative trans. at $65.28 per share. | 99,747 |
09/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
476 | Derivative/Non-derivative trans. at $65.28 per share. | 31,073 |
09/10/2022 |
Johanna Mercier Chief Commercial Officer |
458 | Derivative/Non-derivative trans. at $65.28 per share. | 29,898 |
09/10/2022 |
Merdad V. Parsey Chief Medical Officer |
481 | Derivative/Non-derivative trans. at $65.28 per share. | 31,399 |
09/10/2022 |
Diane E. Wilfong SVP, Controller & CAO |
148 | Derivative/Non-derivative trans. at $65.28 per share. | 9,661 |
09/10/2022 |
Daniel P. O'Day Chairman & CEO; Director |
3,301 | Derivative/Non-derivative trans. at $0 per share. | 0 |
09/10/2022 |
Andrew D. Dickinson Chief Financial Officer |
1,027 | Derivative/Non-derivative trans. at $0 per share. | 0 |
09/10/2022 |
Johanna Mercier Chief Commercial Officer |
990 | Derivative/Non-derivative trans. at $0 per share. | 0 |
09/10/2022 |
Merdad V. Parsey Chief Medical Officer |
1,039 | Derivative/Non-derivative trans. at $0 per share. | 0 |
09/10/2022 |
Diane E. Wilfong SVP, Controller & CAO |
318 | Derivative/Non-derivative trans. at $0 per share. | 0 |